Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Cents and Sensibility - Kimberly and Friends' Consortium -- Ignore unavailable to you. Want to Upgrade?

To: KevinMark who wrote (73278)	2/9/2000 5:05:00 PM
From: EtTuBrute	Read Replies (2) \| Respond to of 108040

CLIC: LOL!!!! I was about ready to scold you for dumping CLIC. Many shareholders are in at much higher levels (me included), so there shouldnt be much resistance. Shorts should really fuel this ride. What we need now from CLIC are those F50 announcements!!! Are you listening CLIC???? Tomorrow could be a short squeeze of huge proportions

To: KevinMark who wrote (73278)	2/9/2000 5:38:00 PM
From: Smart_Money	Respond to of 108040

DSCI has new patent out that detect skin cancer very early! Taken the below from the patent filling: Currently, the clinical diagnosis of skin disease is generally accomplished by visual inspection under white light illumination. In this process, the reflectance pattern of a skin lesion is examined. Visual diagnosis alone may not be particularly accurate for the early detection of skin cancer since many skin conditions have a similar appearance under white light. Therefore, when a suspect lesion is identified by visual examination, a biopsy is often performed for a definitive diagnosis. Not only is it crucial to diagnose skin pre-cancer or cancer at its early stage when it is curable, it is also important to improve the clinical diagnosis of suspect skin lesions so as to avoid unnecessary skin biopsies.